Extremely potent, rapid and costimulation‐independent cytotoxic T‐cell response against lymphoma cells catalyzed by a single‐chain bispecific antibody

Torsten Dreier, Grit Lorenczewski, Christian Brandl, +7

International Journal of Cancer

ImmunologyImmunologic MechanismCd4 T Cell ResponsesImmune Cell TherapyImmunotherapy +17

Serial killing of tumor cells by cytotoxic T cells redirected with a CD19‐/CD3‐bispecific single‐chain antibody construct

Patrick Hoffmann, Robert Hofmeister, Klaus Brischwein, +6

International Journal of Cancer

Cytotoxic T CellsImmunologyImmunoeditingImmunodominanceTumor Cells +15

Mode of cytotoxic action of T cell-engaging BiTE antibody MT110

Cornelia Haas, Eva Krinner, Klaus Brischwein, +5

Immunobiology

Cytotoxic ActionAutoimmune DiseaseImmunologyImmunodominanceImmunologic Mechanism +7

T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells

Ralf Lutterbuese, Tobias Raum, Roman Kischel, +13

Proceedings of the National Academy of Sciences

Braf-mutated Crc LinesCancer ImmunosurveillanceLow Doses GrowthMedicineT-regulatory Cell +9

Efficient surveillance of pig populations using oral fluids

Alejandro Ramirez, Chong Wang, John Prickett, +10

Preventive Veterinary Medicine

Animal ScienceVeterinary ScienceEducationBiostatisticsPorcine Disease +4

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

Alison D. Marshall, Evan B. Cunningham, Stine Nielsen, +38

˜The œLancet. Gastroenterology & hepatology

VaccinationHcv InfectionViral HepatitisAntiviral Drug DevelopmentAntiviral Therapy +5

Regression of Human Prostate Cancer Xenografts in Mice by AMG 212/BAY2010112, a Novel PSMA/CD3-Bispecific BiTE Antibody Cross-Reactive with Non-Human Primate Antigens

Matthias Friedrich, Tobias Raum, Ralf Lutterbuese, +15

Molecular Cancer Therapeutics

Preclinical Characterization of AMG 330, a CD3/CD33-Bispecific T-Cell–Engaging Antibody with Potential for Treatment of Acute Myelogenous Leukemia

Matthias Friedrich, Anja Henn, Tobias Raum, +11

Molecular Cancer Therapeutics

Hematological MalignancyCell TherapyImmunologyHematologyTumor Immunity +12

The present and future disease burden of hepatitis <scp>C</scp> virus (<scp>HCV</scp>) infections with today's treatment paradigm – volume 2

Angelos Hatzakis, Vladimir Chulanov, Adrián Gadano, +86

Journal of Viral Hepatitis

Viremic PopulationAutoimmune Liver DiseaseViral HepatitisFuture Disease BurdenViremic Prevalence +17

Reverse TCR repertoire evolution toward dominant low-affinity clones during chronic CMV infection

Kilian Schober, Florian Voit, Simon Grassmann, +20

Nature Immunology

Chronic Cmv InfectionViral PersistencePathogenesisImmunologyViral Pathogenesis +7